New asthma pill ADO-5030 enters first human tests
Symptom relief
Not yet recruiting
This early-stage trial tests a single oral dose of ADO-5030 in 36 adults with mild-to-moderate asthma. Researchers will check safety and how the drug affects breathing during a controlled airway challenge. The goal is to gather initial data, not to prove the drug works yet.
Phase: PHASE1 • Sponsor: Adovate • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC